SOX10 and myoepithelial tumor: SOX10 was first described in 2008 as a pan-schwannian and melanocytic marker when its expression was reported in all cases of neurofibroma, schwannoma, myoepithelioma of salivary gland, and 97% cases of melanoma [24].